Home Blogs Pharma Sector Grew by 6% after GST
The smallcase Newsletter

Pharma Sector Grew by 6% after GST

Pharma Sector Grew by 6% after GST
Reading Time: 1 minutes

Analysts expect improved performance from pharma sector

According to government sources, after implementation of GST, the pharma sector grew by 6% to Rs 1,31,312 crores on a year-on-year basis till 31 May 2018. Post GST, exports of the pharma sector also grew by 10% to Rs 3,03,526 crores. As per estimates, the export figure for the current year is likely to be Rs 3,27,700 crores, which will be almost 12% higher than the export figure of the pre-GST regime.

Analysts expect the pharma sector to improve its financials and returns trajectory in the near future. Normalizing regulatory and concentration risks, entry into complex and specialty drugs, and currency tailwinds are all expected to benefit the sector. Pricing environment in the US has also been improving and the trend is likely to continue over the next 2 quarters. Analysts believe earnings growth for larger generic players should be upwards of 15% over the FY18-20 period.

Investors can benefit from the growth of the pharma sector by investing in the smallcase Pharma Tracker.

smallcase pharma tracker

Pace of construction of highways picks up

33,361 km of highways have been built over the previous 4.5 years, higher than construction done in the 7 years between FY2008-FY2014. The pace of construction has also picked up in recent years. In FY2014, 11.7 km/day was constructed whereas it is 27 km/day in FY2018. While the government awarded 17,055 km of highway projects during 2017-18, 20,000 km of highways is expected to be awarded during 2018-19.

Budgetary allocation sought for road and transport projects is also expected to be higher for the 2019-20 period. The Ministry of Road Transport and Highways is expected to seek Rs 85,000 to Rs 89,000 crore to complete the Bharatmala project. Under the scheme, the aim is to construct 34,800 km of highways at an investment of Rs 5,35,000 crore in the first phase by 2022.

Investments in infrastructure will generate jobs, promote tourism and play a catalytic role in overall growth and development of the Indian economy. Investors can take exposure to the infrastructure sector by buying the smallcase Infra Tracker.

The tracker has gained 9.70% over the previous month compared to Nifty returns of 3.67%.

smallcase infra tracker

Markets update

Benchmark indices ended the week on a positive note supported by a drop in oil prices and strengthening Rupee. Nifty closed up 0.92% at 10,682.2 whereas Sensex closed at 35,457.2, up 0.85%.

Industrial Production for September grew by 4.5% compared to analyst consensus of 4.3%. Consumer price inflation dropped to 3.31% in October compared to 3.7% the previous month.

You may want to read

image Indian Markets Celebrate New Milestones 
Reading Time: 3 minutes
India's Q2 GDP performance stole the show, clocking in at an impressive 7.6%, a pleasant surprise that outpaced the general consensus. Notably, India maintained its lead over China, which posted a GDP growth of 4.9% in the July-September quarter.
image Beyond the Hype: Are IPOs a Hit or Miss?
Reading Time: 3 minutes
Last week on the D-street was like an IPO carnival! The initial public offering (IPO) market seems to be in an unprecedented bull wave, with the debut of five IPOs aiming to raise ₹7,400 crore from investors. This is no small feat — five IPOs in a week is a rare sight. So, diving into this week, let's explore India's consumption story. Amidst all the talk about India becoming a major economy, increased consumption stands out as a crucial pillar for this growth.
image The Power of The Great Indian Consumer 
Reading Time: 4 minutes
Even in the tough times of 2020, the festive season was a saving grace, injecting a much-needed boost into the economy. It's incredible how the Indian consumer wields such influence. So, diving into this week, let's explore India's consumption story. Amidst all the talk about India becoming a major economy, increased consumption stands out as a crucial pillar for this growth.

Your email address will not be published. Required fields are marked *

Pharma Sector Grew by 6% after GST
Share via Whatsapp